Buprenorphine: an old dog with new tricks

Curr Opin Support Palliat Care. 2025 Mar 1;19(1):59-64. doi: 10.1097/SPC.0000000000000743. Epub 2025 Jan 30.ABSTRACTPURPOSE OF REVIEW: The survival rate of patients with a cancer or palliative care diagnosis has improved over the years although pain remains a debilitating symptom that many patients still require treatment with opioids. Compared to full mu-opioid receptor agonists such as morphine and oxycodone, buprenorphine continues to remain a second- or third-line choice in this group of patients.We have reviewed the pharmacology and clinical utility of buprenorphine to stimulate debate around the first-line use of buprenorphine in the management of pain in cancer patients.RECENT FINDINGS: Buprenorphine…
Origen: Buprenorphine: an old dog with new tricks – PubMed